Owning the Rails of the Tokenized-Stock Unlock — Quick Take
Financial Services was the #1 sector in the Sat 19 Sep US VolumeSurge scan — 16 of 50 names passed all three filters, versus 10 Technology and 9 Healthcare — and Coinbase was the screen's #3 top pick, +11.66% to $194.25 on $4.2B of turnover (~21.9M shares). It is the largest name in that sector print not already covered in this series (Robinhood was covered on 20 Sep, SanDisk on 4 Aug). The fuel under the whole group is a single regulatory event: on 17 Sep the SEC issued its five-year "Innovation Exemption", a framework letting qualifying Tokenized Securities Venues (TSVs) list and trade tokenized US equities — including on-chain AMMs — without registering as exchanges, provided the tokens carry the same rights as the underlying shares (dividends and voting). CoinDesk's 20 Sep follow-up named Coinbase, Robinhood and Circle as the early winners. Coinbase already runs a tokenized-equity book offshore, like Robinhood, Kraken and Gemini — the difference is that the SEC has now opened the US version of that market, and the exemption excludes synthetic price-exposure products, which is where the cheapest competing offers sit. COIN has never been covered in this series.
| Year | Revenue | Rev Growth | Op Margin* | Net Income |
|---|---|---|---|---|
| FY2022 | $3.2B | −59% | neg. | −$2.6B |
| FY2023 | $3.1B | −3% | ~2% | +$0.1B |
| FY2024 | $6.6B | +111% | ~35% | +$2.6B |
| FY2025 | $7.2B | +9% | 20.0% | +$1.3B |
| TTM (to Q2'26) | $6.3B | −10% | neg. | −$0.95B |
*Op margin for FY2025 is as reported (20.0%); earlier years are approximations, because Coinbase's GAAP operating line is distorted by crypto-asset mark-to-market gains and losses — FY2024's $2.6B net income and FY2022's $2.6B loss are both largely that. TTM window = Q3 FY2025–Q2 FY2026, summed from filings: revenue $6.3B (−10.4% YoY), net loss $948.1M, diluted EPS −$3.75, but operating cash flow +$1.7B. TTM revenue is down because the crypto cycle cooled, not because the franchise shrank.
| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Total revenue | $1.22B | $1.41B |
| Net revenue | $1.15B | — |
| — Transaction revenue | $599.2M | $755.8M |
| — Subscription & services | $555.1M (48% of net rev) | — |
| Net income / (loss) | −$359.5M | −$394.1M |
| Adjusted EBITDA | +$208M | +$303M |
| Crypto trading volume share | 10.3% (record) | 8.6% (record then) |
Revenue fell 14% QoQ in Q2 (after −21% in Q1) — the clean cycle read. What did not fall: market share (8.6% → 10.3% of global crypto volume, both all-time highs), the subscription-and-services mix (48% of net revenue; 88% of net revenue excluding Bitcoin spot trading), and adjusted EBITDA, which stayed positive for a 14th straight quarter. Retail derivatives are running above $200M annualized and prediction markets above $100M annualized. Balance sheet: $13.1B of equity, P/B 3.9x, P/S 8.2x on the 19 Sep close of $194.25 (~264M shares outstanding → ~$51.3B market cap). Analyst consensus is ~$222 (34 analysts, S&P Global), range $185–$475.
The interesting part is not the exemption itself — every venue got that — it is that Coinbase is the only name in the group combining a US-listed balance sheet, a live tokenized-equity book and custody stack, and enough non-spot revenue (48% of net revenue) to fund a take-rate war it will not win outright but can survive longest. The risk is the entry price: 8x sales on negative TTM earnings, after an 11.7% catalyst-day pop, with a consensus target that already bakes in the win. This is a structurally interesting hold on the tokenization rail, not a clean entry price today — if you want it, you want it on a volume-driven de-rating, not on the exemption headline.
Disclaimer: AI-generated quick take for informational purposes only. Not investment advice. Data from public filings and financial data providers.